latanoprostene bunod Ophthalmic solution 0.24 % - 2.5 ml, 5 ml
Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #551
India-based sterile injectables manufacturer and CDMO with multiple decades of operational experience. Rx injectable portfolio spanning several specialty therapy areas is supplied to regulated markets including North America, Europe, and Australia. Facilities hold US FDA, EU-GMP, and PMDA approvals.
Manufacturer usually replies in 21 days